PORTLAND, Maine, June 16, 2020 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Corporation to Present at Lytham Partners Virtual Investor Conference
On Tuesday, May 20th at 11:00 am ETPORTLAND, Maine, May 14, 2020 -- ImmuCell Corporation (NASDAQ: ICCC) a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of...
ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders
PORTLAND, Maine, May 14, 2020 -- ImmuCell Corporation (Nasdaq: ICCC) (the "Company" or "ImmuCell"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Unaudited Financial Results for the First Quarter Ended March 31, 2020
PORTLAND, Maine, May 13, 2020 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell to Announce Unaudited Financial Results for First Quarter of 2020
Conference Call Scheduled for Thursday, May 14, 2020 at 9:00 AM ETPORTLAND, Maine, May 07, 2020 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and...
ImmuCell Receives $938,000 in Support under the Paycheck Protection Program
PORTLAND, Maine, April 14, 2020 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Preliminary, Unaudited Product Sales Results for the Quarter Ended March 31, 2020
PORTLAND, Maine, April 02, 2020 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Refinancing of its Bank Debt
PORTLAND, Maine, March 11, 2020 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Correction to its Reported Unaudited Loss Per Share from ($0.06) to ($0.04) for the Quarter Ended December 31, 2019
PORTLAND, Maine, Feb. 19, 2020 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2019
PORTLAND, Maine, Feb. 18, 2020 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell to Announce Preliminary Financial Results for the Year Ended December 31, 2019
Conference Call Scheduled for Wednesday, February 19, 2020 at 9:00 AM ETPORTLAND, Maine, Feb. 13, 2020 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven...
ImmuCell Announces Preliminary, Unaudited Product Sales Results for the Year Ended December 31, 2019
PORTLAND, Maine, Jan. 21, 2020 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Unaudited Financial Results for Third Quarter of 2019
PORTLAND, Maine, Nov. 11, 2019 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell to Announce Unaudited Financial Results for Third Quarter of 2019
Conference Call Scheduled for Monday, November 11, 2019 at 4:30 PM ETPORTLAND, Maine, Nov. 05, 2019 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company") - a growing animal health company that develops, manufactures and markets scientifically-proven and...
ImmuCell Enters into Lease Agreement for a Facility to Expand First Defense® Production Capacity
PORTLAND, Maine, Sept. 17, 2019 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company") - a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of...
ImmuCell Announces an Agreement Covering the Formulation and Aseptic Filling of Syringes for Re-Tain™
PORTLAND, Maine, Sept. 11, 2019 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company") - a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of...
ImmuCell Receives FDA Response To First CMC Submission for Re-Tain™
Second Submission Anticipated Around Q3 2020 PORTLAND, Maine, Aug. 29, 2019 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company") - a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that...
ImmuCell Announces Unaudited Financial Results for Second Quarter of 2019
PORTLAND, Maine, Aug. 12, 2019 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company") - a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell to Announce Unaudited Financial Results for Second Quarter of 2019
Conference Call Scheduled for Tuesday, August 13, 2019 at 9:00 AM ETPORTLAND, Maine, Aug. 06, 2019 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company") - a growing animal health company that develops, manufactures and markets scientifically-proven and...
ImmuCell Announces Unaudited Financial Results for First Quarter of 2019
PORTLAND, Maine, May 13, 2019 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company") - a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell to Announce Unaudited Financial Results for First Quarter of 2019
Conference Call Scheduled for Tuesday, May 14, 2019 at 9:00 AM ETPORTLAND, Maine, May 07, 2019 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company") - a growing animal health company that develops, manufactures and markets scientifically-proven and...
ImmuCell Corporation Announces Closing of $9 Million Public Offering of Common Stock
PORTLAND, Maine, March 29, 2019 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Corporation Announces Pricing of $9.0 Million Public Offering of Common Stock
PORTLAND, Maine, March 27, 2019 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Corporation Announces Commencement of Public Offering of Common Stock
PORTLAND, Maine, March 26, 2019 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Submission of Manufacturing Technical Section for its Purified Nisin Product
PORTLAND, Maine, Feb. 28, 2019 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Preliminary Financial Results for Fourth Quarter and Full Year 2018
PORTLAND, Maine, Feb. 13, 2019 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company") - a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell to Announce Financial Results for Fourth Quarter and Full Year 2018
Conference Call Scheduled for Thursday, February 14, 2019 at 9:00 AM ET PORTLAND, Maine, Feb. 06, 2019 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven...
ImmuCell Announces USDA Approval of Dual-Force™ First Defense®
PORTLAND, Maine, Dec. 11, 2018 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Financial Results for Third Quarter of 2018
PORTLAND, Maine, Nov. 13, 2018 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell to Participate at 9th Annual Craig-Hallum Alpha Select Conference
PORTLAND, Maine, Nov. 08, 2018 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell to Announce Financial Results for Third Quarter of 2018
Conference Call Scheduled for Wednesday, November 14, 2018 at 9:00 AM ET PORTLAND, Maine, Nov. 07, 2018 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven...
ImmuCell Announces Issuance of Human Food Safety Technical Section Complete Letter for its Purified Nisin Product
PORTLAND, Maine, Sept. 25, 2018 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Financial Results for Second Quarter of 2018
PORTLAND, Maine, Aug. 13, 2018 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell to Announce Financial Results for Second Quarter of 2018
Conference Call Scheduled for Tuesday, August 14, 2018 at 9:00 AM ET PORTLAND, Maine, Aug. 07, 2018 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and...
ImmuCell Hires Senior Director of Quality
PORTLAND, Maine, Aug. 07, 2018 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Sale of Certain Non-Core Assets
PORTLAND, Maine, July 25, 2018 -- ImmuCell Corporation (Nasdaq:ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Preliminary Sales Results for Second Quarter of 2018
PORTLAND, Maine, July 10, 2018 -- ImmuCell Corporation (Nasdaq:ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell to Join Russell Microcap Index
PORTLAND, Maine, June 25, 2018 -- ImmuCell Corporation (Nasdaq:ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Financial Results for First Quarter of 2018
PORTLAND, Maine, May 14, 2018 -- ImmuCell Corporation (Nasdaq:ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell to Announce Financial Results for First Quarter of 2018
Conference Call Scheduled for Monday, May 14, 2018 at 4:30 PM ET PORTLAND, Maine, May 07, 2018 -- ImmuCell Corporation (Nasdaq:ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and...
ImmuCell Announces Preliminary Financial Results for Fourth Quarter and Full Year 2017
PORTLAND, Maine, Feb. 08, 2018 -- ImmuCell Corporation (Nasdaq:ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell to Announce Financial Results for Fourth Quarter and Full Year 2017
Conference Call Scheduled for Thursday, February 8, 2018 at 4:30 PM ET PORTLAND, Maine, Feb. 05, 2018 -- ImmuCell Corporation (Nasdaq:ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and...
ImmuCell Appoints Two New Members to its Board of Directors
PORTLAND, Maine, Jan. 30, 2018 -- ImmuCell Corporation (Nasdaq:ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Corporation Announces Closing of $3 Million Public Offering of Common Stock
PORTLAND, Maine, Dec. 21, 2017 -- ImmuCell Corporation ("ImmuCell" or the "Company") (Nasdaq:ICCC), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Corporation Announces Pricing of $3 Million Public Offering of Common Shares
PORTLAND, Maine, Dec. 19, 2017 -- ImmuCell Corporation ("ImmuCell" or the "Company") (Nasdaq:ICCC), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Financial Results for Third Quarter of 2017
PORTLAND, Maine, Nov. 13, 2017 -- ImmuCell Corporation (Nasdaq:ICCC), a growing animal health company that develops, manufactures and markets scientifically-proven products that improve the health and productivity of dairy and beef cattle, today announced unaudited...
ImmuCell Achieves USDA Approval of New Product Claim to Prevent Rotavirus Infections
PORTLAND, Maine, Nov. 13, 2017 -- ImmuCell Corporation (Nasdaq:ICCC), a growing animal health company that develops, manufactures and markets scientifically-proven products that improve the health and productivity of dairy and beef cattle, today announced that the...
ImmuCell Announces Completion of Construction of Nisin Production Facility
PORTLAND, Maine, Nov. 07, 2017 -- ImmuCell Corporation (Nasdaq:ICCC), a growing animal health company that develops, manufactures and markets scientifically-proven products that improve the health and productivity of dairy and beef cattle, today announced completion...
ImmuCell to Announce Financial Results for Third Quarter of 2017
Conference Call Scheduled for Monday, November 13, 2017 at 4:30 PM ET PORTLAND, Maine, Nov. 02, 2017 -- ImmuCell Corporation (Nasdaq:ICCC), a growing animal health company that develops, manufactures and markets scientifically-proven products that improve the health...
ImmuCell Announces Expansion of Sales and Marketing Team
PORTLAND, Maine, Sept. 13, 2017 -- ImmuCell Corporation (Nasdaq:ICCC), a growing animal health company that develops, manufactures and markets scientifically-proven products that improve health and productivity in the dairy and beef industries, today announced the...
